Recruiting EARLY_PHASE1 Travelers Diarrhea

New treatment option for Travelers Diarrhea

Official title G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies

ClinicalTrials.gov ID: NCT06556940

What this study is testing

What is LMN-401?

LMN-401 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for travelers diarrhea.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The goal of this interventional study is to learn about the intraluminal pharmacokinetics (PK) of the investigational drug LMN-401 in adult healthy volunteers with ileostomies. LMN-401 is being developed as a potential new treatment for Traveler's Diarrhea.
  • Phase 1: an early, usually small safety study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 19 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Aged 19 years and above
  • Medically stable
  • Mature and stable ileostomy (no revisions in past 6 months)
  • Willing and able to participate in all study visits
  • Willing and able to provide informed consent

You likely can't join if

  • Unable or unwilling to provide adequate informed consent
  • Gastroparesis
  • Using or planning to use anti-diarrheal medication
  • Using or planning to use opioids
  • Clinically significant disease
  • Women who are pregnant, intending to become pregnant, or breastfeeding
See the full eligibility criteria
Who can join
  • Aged 19 years and above
  • Medically stable
  • Mature and stable ileostomy (no revisions in past 6 months)
  • Willing and able to participate in all study visits
  • Willing and able to provide informed consent
What rules you out
  • Unable or unwilling to provide adequate informed consent
  • Gastroparesis
  • Using or planning to use anti-diarrheal medication
  • Using or planning to use opioids
  • Clinically significant disease
  • Women who are pregnant, intending to become pregnant, or breastfeeding
  • Non-English speakers

The study team makes the final eligibility decision.

Where it's taking place

  • Maroochydore, Australia

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 19 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Maroochydore, Australia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.